NASDAQ : NLTX

Neoleukin Therapeutics, Inc. — Earnings Estimates

$3.49 USD

$0.05 (1.45%)

Volume
109.1K
Average Volume
6.08K
Market Capitalization
$8.2M
P/E Ratio
-4.42
Dividend Yield
0.00%
Price Target
Year High
$18.80
Year Low
$3.42
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$10.64

Annual earnings financials

NLTX financial data with annual/quarterly toggle

NLTX GAAP EPS - Annual & Quarterly

NLTX Sales Revenue - Annual & Quarterly

NLTX Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

NLTX Estimated and Actual Revenue by Quarter
NLTX Estimated and Actual EPS by Quarter
NLTX Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2024-09-30 0 - - - - - -
2024-06-30 0 - - - - - -
2024-03-30 0 - - - - - -
2023-12-30 0 - - - - - -
2023-09-30 0 - - - - - -
2023-06-30 0 - - - - - -
NLTX Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2024-09-30 0 86.56M 86.56M 86.56M - - -
2024-06-30 0 75.4M 75.4M 75.4M - - -
2024-03-30 0 88.53M 88.53M 88.53M - - -
2023-12-30 0 117.28M 117.28M 117.28M - - -
2023-09-30 0 -8.42M -8.42M -8.42M - - -
2023-06-30 0 -42.12M -42.12M -42.12M - - -
NLTX Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2024-09-30 0 - - - 0 1.54141 1.54141 1.54141
2024-06-30 0 - - - 0 1.34259 1.34259 1.34259
2024-03-30 0 - - - 0 1.57645 1.57645 1.57645
2023-12-30 0 - - - 1 2.08841 2.08841 2.08841
2023-09-30 0 - - - 0 -0.15 -0.15 -0.15
2023-06-30 0 - - - 0 -0.75 -0.75 -0.75